부산대학교 도서관

Nally E; Young M; Chauhan V; Wells C; Szabados B; Powles T; Jackson-Spence F

Cancer Management and Research, Vol 16, Pp 467-475 (2024)

Lemelin A; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada.; Maj D; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada. Electronic address: David.Maj@AlbertaHealthServices.ca.; Takemura K; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Boyne DJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Warkentin MT; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Brenner DR; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Cheung WY; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Wells C; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada.; Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Contreras LM; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA.; Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA.; Beuselinck B; Department of General Medical Oncology and Laboratory for Experimental Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; McKay RR; Department of Oncology, Moores Cancer Center, University of California San Diego, La Jolla, USA.; Szabados B; Barts Cancer Institute, Queen Mary University of London, London, UK.; Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK.; Yuasa T; Department of Genitourinary Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Ludwig L; Ipsen Biopharmaceuticals Canada, Inc., Mississauga, Canada.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Heng DYC; Arthur JE Child Comprehensive Cancer Centre, University of Calgary, Calgary, Canada.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Day E; Department of Urology University College London Hospital London UK.; Upadhyay P; Medical School University College London London UK.; Padhiyar R; Medical School University College London London UK.; Tzelves L; 2nd Department of Urology, Sismanogleio Hospital National and Kapodistrian University of Athens Greece.; Szabados B; Department of Urology University College London Hospital London UK.; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute Queen Mary University of London London UK.; Ta A; Department of Urology St Vincent Hospital Melbourne Australia.; Sridhar A; Department of Urology University College London Hospital London UK.; Kelly J; Department of Urology University College London Hospital London UK.

Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101764975 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-4526 (Electronic) Linking ISSN: 26884526 NLM ISO Abbreviation: BJUI Compass Subsets: PubMed not MEDLINE

Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Comprehensive Cancer Center, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.; Guerrero-Ramos F; Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Crispen PL; Department of Urology, University of Florida, Gainesville, FL.; Herrera-Imbroda B; Urology Department, Hospital Universitario Virgen de la Victoria, IBIMA-Plataforma BIONAND, Málaga, Spain.; Garje R; Miami Cancer Institute, Miami, FL.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Urology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; Peyton CC; Department of Urology, University of Alabama at Birmingham, Birmingham, AL.; Pradere B; Department of Urology, UROSUD, La Croix Du Sud Hospital, Quint-Fonsegrives, France.; Ku JH; Seoul National University Hospital, Seoul, South Korea.; Shore N; START Carolina Research, Myrtle Beach, SC.; Bögemann M; Department of Urology, Münster University Hospital, Münster, Germany.; Preston MA; Department of Urologic Surgery, Brigham & Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Xylinas E; Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France.; Sanchez de Llano C; Johnson & Johnson, Madrid, Spain.; Gong C; Johnson & Johnson, Raritan, NJ.; Hasan M; Johnson & Johnson, Spring House, PA.; Urtishak K; Johnson & Johnson, Spring House, PA.; Battaglia S; Johnson & Johnson, Spring House, PA.; Stitou H; Johnson & Johnson, Issy-les-Moulineaux, France.; Bhanvadia S; Johnson & Johnson, Spring House, PA.; Sweiti H; Johnson & Johnson, Spring House, PA.; Psutka SP; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; In Process

Coca Membribes S; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK. sara.membribes@nhs.net.; Szabados B; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK.; Powles T; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK. thomas.powles1@nhs.net.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

Powles T; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London. Electronic address: thomas.powles1@nhs.net.; Hussain SA; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield.; Climent MA; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia.; Carbonero IG; Hospital Virgen de la Salud, Toledo.; Molina-Cerrillo J; Hospital Universitario Ramón y Cajal, Madrid.; Puente J; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid.; Borrega P; Hospital San Pedro de Alcántara, Cáceres, Spain.; Malik J; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.; Dourthe LM; Medical Oncology, Clinique Sainte-Anne, Strasbourg, France.; Jones R; School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.; Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid.; Durán I; Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain.; Loriot Y; Department of Cancer Medicine, Institut de Cancérologie Gustave Roussy, Villejuif, France.; Priyadarshini G; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London.; Szabados B; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London.; Jamal F; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London.; Wang YQ; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London.; Kotriwala N; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London.; Jackson-Spence F; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London.; Ackerman C; Barts Cancer Institute (ECMC and NIHR Biomedical Research Centre), Queen Mary University of London, London.; Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain; Facultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Day E; Department of Urology, Ayr University Hospital, Ayr, UK.; Bizzarri FP; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Mackenzie C; Department of Gynae-Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Szabados B; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Nelson AW; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Colquhoun AJ; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Perry MJ; Department of Urology, Royal Surrey NHS Foundation Trust, Surrey, UK.; Kelly JD; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.; Lobo N; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. niyati.lobo3@nhs.net.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500082 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4820 (Electronic) Linking ISSN: 17594812 NLM ISO Abbreviation: Nat Rev Urol Subsets: MEDLINE

Day E; Department of Urology University College London Hospital NHS Foundation Trust London UK.; Aquilina R; School of Medicine University College London London UK.; Tzelves L; 2nd Department of Urology Sismanogleio Hospital, National and Kapodistrian University of Athens Greece.; Sridhar A; Department of Urology University College London Hospital NHS Foundation Trust London UK.; Ta A; Department of Urology St Vincent's Hospital Melbourne Australia.; Kelly J; Department of Urology University College London Hospital NHS Foundation Trust London UK.; Szabados B; Department of Urology University College London Hospital NHS Foundation Trust London UK.; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute Queen Mary University of London London UK.

Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101764975 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-4526 (Electronic) Linking ISSN: 26884526 NLM ISO Abbreviation: BJUI Compass Subsets: PubMed not MEDLINE

Membribes SC; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK.; Nally E; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK.; Jackson-Spence F; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK.; Graham C; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK.; Lalwani S; Barts Health NHS Trust, London, UK.; Szabados B; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK.; Powles T; Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

de Jong JJ; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Maasstad Hospital, Rotterdam, the Netherlands.; Reike MJ; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Department of Urology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany.; Lotan Y; University of Texas Southwestern, Dallas, Texas.; Seiler R; Department of Urology, Hospital Center Biel, Biel, Switzerland.; Department of BioMedical Research, University of Bern, Bern, Switzerland.; Davicioni E; Veracyte Inc., San Francisco, California.; Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.; Vita-Salute San Raffaele University Milan, Milan, Italy.; Powles T; Barts Cancer Center, London, United Kingdom.; Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Szabados B; Barts Cancer Center, London, United Kingdom.; Gibb EA; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Bickley LJ; Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, UK. leo.jurascheck1@nhs.net.; Yang YH; Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, UK.; Jackson-Spence F; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Toms C; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Sng C; Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, UK.; Flanders L; Barts Health NHS Trust, St Bartholomew's Hospital, West Smithfield, London, UK.; Bex A; Department of Urology, The Royal Free London NHS Foundation Trust, London, UK.; Division of Surgery and Interventional Science, University College London, London, UK.; Department of Urology, Netherlands Cancer Institute, Amsterdam, Netherlands.; Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.

Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE

Lim KHJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.; Advanced Immunotherapy and Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kindom.; Tippu Z; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Corrie PG; Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Hubank M; Department of Translational Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.; Division of Molecular Pathology, Clinical Genomics (Research), The Institute of Cancer Research, London, United Kingdom.; Larkin J; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Renal Cancer and Melanoma Team, Institute of Cancer Research, London, United Kingdom.; Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, United Kingdom.; Microbiotica Limited, Cambridge, United Kingdom.; Stares M; Edinburgh Cancer Centre, NHS Lothian, Edinburgh, United Kingdom.; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom.; Stewart GD; Department of Surgery, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Strange A; Software Engineering and Artificial Intelligence, The Francis Crick Institute, London, United Kingdom.; Symeonides SN; Edinburgh Cancer Centre, NHS Lothian, Edinburgh, United Kingdom.; Edinburgh Experimental Cancer Medicine Centre, University of Edinburgh, Edinburgh, United Kingdom.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Turner NC; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Breast Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Waddell T; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Zelenay S; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.; Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, United Kingdom.; Salto-Tellez M; Integrated Pathology Unit, Division of Molecular Pathology, The Institute of Cancer Research London and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.; Precision Medicine Centre of Excellence, The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom.; Dive C; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, United Kingdom.; Cancer Research UK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom.; Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.; Renal and Skin Units, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Renal Cancer and Melanoma Team, Institute of Cancer Research, London, United Kingdom.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Yang YH; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Ansel S; Beatson West of Scotland Cancer Centre, Glasgow, UK.; Meerveld-Eggink A; Department of Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Jackson-Spence F; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rallis K; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Brian P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Choy J; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Sng C; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Adeniran P; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Amin J; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Galope S; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Anderson N; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Bex A; Department of Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Urology, The Royal Free London NHS Foundation Trust, University College London Division of Surgery and Interventional Science, London, UK.; Powles T; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.; Venugopal B; Beatson West of Scotland Cancer Centre, Glasgow, UK.; Szabados B; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: bernadett.szabados@nhs.net.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Bellmunt J; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Russell BM; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Szabados B; Barts Cancer Institute (Barts Health NHS Trust), London, United Kingdom.; Valderrama BP; Hospital Virgen del Rocio, University Hospital Virgen del Rocío, Seville, Spain.; Nadal R; Division of Oncology, Department of Medicine, University of Washington, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE

Takemura K; Tom Baker Cancer Centre, University of Calgary, Calgary, Canada; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: kosuke.takemura@albertahealthservices.ca.; Lemelin A; Tom Baker Cancer Centre, University of Calgary, Calgary, Canada.; Ernst MS; Tom Baker Cancer Centre, University of Calgary, Calgary, Canada.; Wells JC; BC Cancer Agency, Vancouver, Canada.; Saliby RM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; El Zarif T; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Labaki C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Basappa NS; Cross Cancer Institute, University of Alberta, Edmonton, Canada.; Szabados B; Barts Cancer Institute, Queen Mary University of London, London, UK.; Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK.; Davis ID; Eastern Health Clinical School, Monash University, Box Hill, Australia.; Wood LA; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Canada.; Lalani AA; Juravinski Cancer Centre, McMaster University, Hamilton, Canada.; McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Lee JL; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Meza L; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Donskov F; Aarhus University Hospital, Aarhus, Denmark; University Hospital of Southern Denmark, Esbjerg, Denmark.; Yuasa T; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Beuselinck B; Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; Gebrael G; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Choueiri TK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, Canada.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Jackson-Spence F; Department of Genitourinary Oncology, Barts Cancer Institute, QMUL, London, UK.; Ackerman C; Department of Genitourinary Oncology, Barts Cancer Institute, QMUL, London, UK.; Jones R; Department of Genitourinary Oncology, University of Glasgow, Glasgow, Scotland, UK.; Toms C; Department of Genitourinary Oncology, Barts Cancer Institute, QMUL, London, UK.; Jovaisaite A; Department of Genitourinary Oncology, Barts Cancer Institute, QMUL, London, UK.; Young M; Department of Genitourinary Oncology, Barts Cancer Institute, QMUL, London, UK.; Hussain S; Department of Genitourinary Oncology, University of Liverpool, Liverpool, UK.; Protheroe A; Department of Genitourinary Oncology, Churchill Hospital, Oxford, UK.; Birtle A; Department of Genitourinary Oncology, Preston Hospital, Preston, UK.; Chakraborti P; Department of Genitourinary Oncology, Derby Hospitals NHS Foundation trust, Derby, UK.; Huddart R; Department of Genitourinary Oncology, Institute of Cancer Research, Sutton, UK.; Jagdev S; Department of Genitourinary Oncology, St James's University Hospital, Leeds, UK.; Bahl A; Department of Genitourinary Oncology, Bristol Haematology and Oncology Centre, Bristol, UK.; Sundar S; Department of Genitourinary Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Crabb S; Department of Genitourinary Oncology, University of Southampton, Southampton UK.; Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, QMUL, London, UK. Electronic address: thomas.powles1@nhs.net.; Szabados B; Department of Genitourinary Oncology, Barts Cancer Institute, QMUL, London, UK.

Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE

Nathan P; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. Electronic address: p.nathan@nhs.net.; Venugopal B; School of Cancer Sciences, Beatson West of Scotland Cancer Centre, Glasgow, UK; University of Glasgow, Glasgow, UK.; Ali J; School of Cancer Sciences, Beatson West of Scotland Cancer Centre, Glasgow, UK.; Allison J; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, UK.; Ceruso M; Medical Affairs, Ipsen Ltd., London, UK.; Charnley N; Department of Oncology, Royal Preston Hospital, Preston, UK.; Griffiths R; Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.; Michael A; Department of Medical Oncology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.; Moore K; Nottingham Cancer Clinical Trials Team, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Perrot V; Medical Affairs Biometry, Ipsen, Boulogne-Billancourt, France.; Prendergast Á; Medical Affairs, Ipsen Ltd., London, UK.; Sharma A; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.; Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK.; Larkin J; Urology and Skin Units, Royal Marsden NHS Foundation Trust, London, UK.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Grant M; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Specialist Kidney Cancer Unit, Royal Free Hospital, Royal Free NHS Foundation Trust, London, UK.; Hockings H; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Lapuente M; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Adeniran P; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Saud RA; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Sivajothi A; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Amin J; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Crusz SM; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Rashid S; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Szabados B; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Wells P; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK.; Boleti E; Specialist Kidney Cancer Unit, Royal Free Hospital, Royal Free NHS Foundation Trust, London, UK.; Powles TB; Barts Cancer Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, Barbican, London, EC1M 6BE, UK. Thomas.powles1@nhs.net.; Department of Oncology, St. Bartholomew's Hospital, Bart's Health NHS Trust, London, UK. Thomas.powles1@nhs.net.

Publisher: Springer Country of Publication: England NLM ID: 8610343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-0154 (Electronic) Linking ISSN: 08858195 NLM ISO Abbreviation: J Cancer Educ Subsets: MEDLINE

Young M; Barts Cancer Institute, Queen Mary University of London, London, UK.; Jackson-Spence F; Barts Cancer Institute, Queen Mary University of London, London, UK.; Beltran L; Department of Cellular Pathology, Barts National Health Service Trust, London, UK.; Day E; Department of Urology, University College London Hospital National Health Service Foundation Trust, London, UK.; Suarez C; Medical Oncology, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Bex A; Department of Urology, The Royal Free London National Health Service Foundation Trust, University College London Division of Surgery and Interventional Science, London, UK; The Netherlands Cancer Institute, Amsterdam, Netherlands.; Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: thomas.powles1@nhs.net.; Szabados B; Barts Cancer Institute, Queen Mary University of London, London, UK; Department of Urology, University College London Hospital National Health Service Foundation Trust, London, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Takemura K; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: kosuke.takemura@jfcr.or.jp.; Yuasa T; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Lemelin A; Tom Baker Cancer Centre, University of Calgary, Calgary.; Ferrier E; Tom Baker Cancer Centre, University of Calgary, Calgary.; Wells JC; BC Cancer Agency, Vancouver, Canada.; Saad E; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Saliby RM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Basappa NS; Cross Cancer Institute, University of Alberta, Edmonton.; Wood LA; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Canada.; Jude E; Olivia Newton-John Cancer Wellness & Research Centre, Heidelberg, Australia.; Pal SK; City of Hope Comprehensive Cancer Center, Duarte, USA.; Donskov F; Aarhus University Hospital, Aarhus; University Hospital of Southern Denmark, Esbjerg, Denmark.; Beuselinck B; Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; Szabados B; Barts Cancer Institute, Queen Mary University of London, London, UK.; Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK.; McKay RR; Moores Cancer Center, University of California San Diego, La Jolla.; Gebrael G; Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.; Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.; Choueiri TK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. Electronic address: https://twitter.com/DrChoueiri.; Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary. Electronic address: https://twitter.com/DrDanielHeng.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE